PharmEasy sets stage for IPO return with new strategy, boosted cash flow

​Online pharmacy player PharmEasy is looking to relaunch its initial public offering (IPO) this year, two years after pulling its IPO application, according to a report by The Economic Times.

The company plans to present its IPO strategy to its board next month, which could include a reverse merger with its publicly listed subsidiary, Thyrocare. PharmEasy intends to use its improved cash flow and restructured business model to gain the confidence of public market investors, the news report said.
​

A source, as quoted by the news report, said that the company will discuss the IPO strategy at the February board meeting, with key focus on reducing cash burn.

Read more